Botulinum Toxin [botulinum toxin A] Injection With Prostate Brachytherapy: A Randomized, Placebo-Controlled Study Monitoring Urinary Symptoms and PSA [prostate specific antigen].

At a glance
Trial Overview
Trial Details
- Identifiers
- Other Details
Interventions
Trial Centres
- Investigators
- Centres
Trial History
References

Trial Profile

Botulinum Toxin [botulinum toxin A] Injection With Prostate Brachytherapy: A Randomized, Placebo-Controlled Study Monitoring Urinary Symptoms and PSA [prostate specific antigen].

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Botulinum-Toxin-A (Primary)
Indications Lower urinary tract symptoms
Focus Therapeutic Use

Most Recent Events

21 Nov 2013 Biomarkers information updated
29 Jan 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
11 Jun 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com